Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
TEVAPHARMIND SP ADR Add to My Watchlist (NSDQ: TEVA) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Teva 56.97 -0.13 (-0.23%) 429,798
5 Basel Street
P.O. Box 3190
Petach Tikva, 49131 IS
97239267267
97239234050 fax
www.tevapharm.com
CEO Shlomo Yanai
Auditor Kesselman & Kesselman
Exchange Traded NQ
ISIN Number US8816242098
CIK Number 818686
NAICS Code 325412
Business Summary
A global pharmaceutical company, which develops, produces and markets generic drugs covering all major treatment categories.
Number of Employees 38,307
Share Fundamentals
Market Cap 51.73B
Shares Outstanding 912.00M
Float N/A
Short Interest 8.98M
Financial Strength
Revenue (TTM) $12,945,000,000
Earnings (TTM) $935,000,000
Quick Ratio 0.9:1
Current Ratio 1.6:1
Total Debt/Equity 0.33:1
Dividend Information
Yield % 0.9
Annual Dividend 0.5
Latest Dividend 0.5 (2009-11-06)
Profitability
Gross Margin 54.0%
EBITDA Margin 12.2%
Profit Margin 8.4%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Real Time Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs